FR2445321A1 - - Google Patents

Info

Publication number
FR2445321A1
FR2445321A1 FR8007757A FR8007757A FR2445321A1 FR 2445321 A1 FR2445321 A1 FR 2445321A1 FR 8007757 A FR8007757 A FR 8007757A FR 8007757 A FR8007757 A FR 8007757A FR 2445321 A1 FR2445321 A1 FR 2445321A1
Authority
FR
France
Prior art keywords
compound
following formula
preparation process
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8007757A
Other languages
English (en)
French (fr)
Other versions
FR2445321B1 (zh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho McNeil Pharmaceutical Inc
Original Assignee
McNeilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/972,579 external-priority patent/US4229462A/en
Priority claimed from US05/972,580 external-priority patent/US4239768A/en
Application filed by McNeilab Inc filed Critical McNeilab Inc
Publication of FR2445321A1 publication Critical patent/FR2445321A1/fr
Application granted granted Critical
Publication of FR2445321B1 publication Critical patent/FR2445321B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/38—Isothioureas containing any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR8007757A 1978-12-22 1980-04-04 Expired FR2445321B1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/972,579 US4229462A (en) 1978-12-22 1978-12-22 Method for controlling hypertension and compositions
US05/972,580 US4239768A (en) 1978-12-22 1978-12-22 Method for relieving irritable bowel syndrome symptoms

Publications (2)

Publication Number Publication Date
FR2445321A1 true FR2445321A1 (zh) 1980-07-25
FR2445321B1 FR2445321B1 (zh) 1983-08-26

Family

ID=27130555

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7931473A Expired FR2444462B1 (fr) 1978-12-22 1979-12-21 Compositions pour controler l'hypertension et les troubles intestinaux comprenant un derive de n-aryl n'2-(imidazolidinylidene)-uree
FR8007757A Expired FR2445321B1 (zh) 1978-12-22 1980-04-04

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7931473A Expired FR2444462B1 (fr) 1978-12-22 1979-12-21 Compositions pour controler l'hypertension et les troubles intestinaux comprenant un derive de n-aryl n'2-(imidazolidinylidene)-uree

Country Status (23)

Country Link
AT (1) AT373878B (zh)
AU (2) AU532332B2 (zh)
CA (1) CA1127651A (zh)
CH (1) CH647236A5 (zh)
DE (1) DE2951213A1 (zh)
DK (1) DK548179A (zh)
ES (1) ES8101558A1 (zh)
FI (1) FI66354C (zh)
FR (2) FR2444462B1 (zh)
GB (2) GB2040681B (zh)
GR (1) GR68018B (zh)
HU (1) HU183013B (zh)
IL (1) IL59019A (zh)
IT (1) IT1126839B (zh)
NL (1) NL7909265A (zh)
NO (1) NO794249L (zh)
NZ (1) NZ192453A (zh)
PH (1) PH16571A (zh)
PT (1) PT70624A (zh)
SE (1) SE7910612L (zh)
SU (1) SU971098A3 (zh)
YU (1) YU314979A (zh)
ZW (1) ZW25379A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216247A2 (en) * 1985-09-18 1987-04-01 Merck & Co. Inc. Use of alpha 2 adrenergic receptor antagonists for the production of pharmaceutical compositions for treating colonic spasm, irritable bowel syndrome and constipation and process for preparing such pharmaceutical compositions

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11516649B2 (en) * 2018-10-29 2022-11-29 Apple Inc. Mechanism to activate and manage a standalone device for cellular service

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296962A (fr) * 1960-08-05 1962-06-22 Geigy Ag J R Nouveaux composés 2-imino-1.3-di-aza et leur préparation
NL267923A (zh) * 1960-08-05

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216247A2 (en) * 1985-09-18 1987-04-01 Merck & Co. Inc. Use of alpha 2 adrenergic receptor antagonists for the production of pharmaceutical compositions for treating colonic spasm, irritable bowel syndrome and constipation and process for preparing such pharmaceutical compositions
EP0216247A3 (en) * 1985-09-18 1989-11-15 Merck & Co. Inc. Use of alpha 2 adrenergic receptor antagonists for the production of pharmaceutical compositions for treating colonic spasm, irritable bowel syndrome and constipation and process for preparing such pharmaceutical compositions

Also Published As

Publication number Publication date
AU5378079A (en) 1980-06-26
FR2445321B1 (zh) 1983-08-26
SU971098A3 (ru) 1982-10-30
IT7951164A0 (it) 1979-12-21
FR2444462A1 (fr) 1980-07-18
GB2113204B (en) 1984-02-01
FR2444462B1 (fr) 1986-08-29
FI794036A (fi) 1980-06-23
GB2040681A (en) 1980-09-03
ES487159A0 (es) 1980-12-16
FI66354B (fi) 1984-06-29
IL59019A (en) 1984-05-31
NO794249L (no) 1980-06-24
GB2040681B (en) 1983-04-13
GR68018B (zh) 1981-10-27
IL59019A0 (en) 1980-03-31
NZ192453A (en) 1982-09-07
ZW25379A1 (en) 1981-07-22
AU566013B2 (en) 1987-10-08
AU532332B2 (en) 1983-09-29
CH647236A5 (de) 1985-01-15
PT70624A (en) 1980-01-01
SE7910612L (sv) 1980-06-23
AU1640083A (en) 1983-11-17
AT373878B (de) 1984-02-27
HU183013B (en) 1984-04-28
FI66354C (fi) 1984-10-10
CA1127651A (en) 1982-07-13
YU314979A (en) 1983-02-28
DK548179A (da) 1980-06-23
ES8101558A1 (es) 1980-12-16
DE2951213A1 (de) 1980-07-10
GB2113204A (en) 1983-08-03
ATA808979A (de) 1983-07-15
NL7909265A (nl) 1980-06-24
IT1126839B (it) 1986-05-21
PH16571A (en) 1983-11-18

Similar Documents

Publication Publication Date Title
FR2406447A1 (fr) Substance antitumorale
FR2392671A1 (fr) Application pharmacologique des acides d2-3-1,4-morpholine-2-carboxyliques substitues
FR2405913A1 (fr) Procede de preparation de polyalcools et de derives de ceux-ci et catalyseur utilisable a cet effet
FR2395269A1 (fr) Procede de preparation de 7,8-dihydro-14-hydroxynormorphinone
FR2383185A1 (zh)
FR2445318A1 (fr) Procede de preparation de 1-(3-mercapto-propanoyl)-l-prolines
FR2366285A1 (fr) (3-amino-5-substitue-6-fluoropyrazinoyl ou pyrazamido) guanidines et leurs derives portant des substituants sur les atomes d'azote du noyau de guanidine, utiles comme medicaments
FR2358141A1 (fr) Nouveaux anesthesiques locaux
FR2436150A1 (fr) Derives de 3'',4''-diacyltylosine utiles comme medicaments
FR2405942A1 (fr) Procede d'obtention du 3-oxa-tricyclo (6.2.1.02,7) undecane-4-one et son utilisation a titre d'agent parfumant
FR2421914A1 (fr) 3-acetoxy-9b-11b-epoxy-pregna-trienes et dienes et procede de preparation de 6a-halogeno-pregna-1,4-diene-3 ones et de 6a halogeno-pregna-4-ene-3-ones correspondants
FR2374291A1 (zh)
FR2445321A1 (zh)
FR2383931A1 (fr) Derives d'oxadiazolopyrimidine
FR2355834A1 (fr) Procede de preparation des 1-phenyl-3-amino pyrazoles
FR2389608A1 (zh)
FR2358380A1 (fr) Procede pour la preparation de cetones cycliques
FR2422676A1 (fr) Complexes catalytiques de phosphorines metalliques
FR2381746A1 (fr) Nouveaux derives encephaliniques a la methionine
FR2375252A1 (fr) Nouveaux glucosides antitumoraux
FR2366307A1 (fr) Antigene utilisable pour la preparation d'anticorps specifiques des cathecolamines
FR2359832A1 (fr) 1,3,5-tris-(2-chloroformyl-oxyethyl)-isocyanurate
FR2405926A1 (fr) (asn2)-thymosine a1 et procede de preparation
JPS5557593A (en) Novel manufacture of compound derived from 77aminothiazolylacetoamidocephalosporanic acid
FR2405916A1 (fr) La 1,7-octadiene-3-one et sa preparation

Legal Events

Date Code Title Description
ST Notification of lapse